T HE operation to correct mitral stenosis has proved its value in the past 8 years. Aortic stenosis can also be palliated surgically but the results are less dramatic, the risk is higher, and the pathologic process often limits the quality of the repair. Operations for mitral and aortic insufficiency are still in the experimental stage, but are improving. This article is concerned chiefly with the selection of patients with predominant mitral stenosis for operation. Such an operation has been termed by us "valvuloplasty." Operations with similar objectives, i.e., fracturing and cutting fused commissures, separating fusion of the chordae tendineae, and withall returning the maximum valvular action to the stenotic complex have been variously designated as "commissurotomy," "valvulotomy," or "valvotomy."
Physicians treating patients with rheumatic mitral valve disease are now faced with the question whether or not to recommend operation. In making such a decision several factors are involved. As in any condition where there are alternative medical and surgical treatments, the decision requires knowledge of the specific medical prognosis, the operative risk, and the results to be gained from surgery. MITRAL Group IV patients are cardiac invalids condemned to a life of complete inactivity under medical treatment, with a relatively short life expectancy. Although the operative risk in these patients remains high, the results are surprisingly good and operation should be offered. Physicians should be alert, however, to urge operation while these patients are still in group III when much can be accomplished at a low operative risk. It is bad practice to wait SELECTION OF PATIENTS FOR MITRAL AND AORTIC VALVULOPLASTY until they have slipped into group IV. While the results of surgery contrast brilliantly with medical therapy in this category, we must not let this conceal the great disservice that has been done the patient by allowing him to move from group III into IV. The operative risk to the patient has increased perhaps 30 times and his potentialities for rehabilitation have diminished.
Operative and Postoperative Prognosis of Mitral Stenosis Our conclusions as to the value of the procedure are based on a study of 1,000 consecutive patients operated upon for predominant mitral stenosis by one of us (D. E. H.).
Many of the patients in this group were diagnosed preoperatively as having some degree of mitral insufficiency in addition to the stenosis. Patients with minor degrees of aortic valve disease and with tricuspid incompetence were included. We have previously reported a follow-up study of the first 500 of these patients' and the more recent data bear out the conclusions reached at that time.
No patients in group I have been operated upon. There have been only 19 in group II, and these have been included in group III for statistical purposes. Group III patients constituted nearly three fourths of the entire group and the remainder were group IV patients.
The mortality of mitral valvuloplasty in the first consecutive 1,000 has steadily fallen, so that the risk in group II and group III patients is now less than 1 per cent. There were but 2 deaths among the group III patients in the last 500 of this series. However, the group IV mortality remains high at about 20 per cent. This emphasizes the importance of operating on patients before they slip from group III to group IV. This deterioration can usually be anticipated.
Seventy-eight per cent of the patients in group III and 62 per cent of patients in group IV showed significant postoperative improvement at the time of the most recent follow-up report. Criteria for improvement have been defined elsewhere. 1 The degree of improvement in group III patients has been maintained over a follow-up time up to 5 years ( fig. 1) improvement from operation is persistent, and the number of significant regressions is small. The same is true for group IV patients. The degree of improvement in group III patients after 6 or more years is less than for the first years but the differences are not significant because of the small number of patients followed.
Some skeptics argue that improvement may be due to the psychologic effect of the procedure or to better medical care and not to the operation itself. We have data, as have others, indicating that the hemodynamics of the circulation actually improve after the operation in a considerable number of patients. This longterm clinical study of a large number of patients constitutes further evidence. The simple fact that the good results persist suggests that the operation has fundamentally altered the patient's course. The ultimate test of the value of this operation, of course, will be whether these patients will survive longer than comparable patients treated medically. under consideration for operation, the degree of mitral stenosis and the extent to which the symptoms are attributable to obstruction at the mitral valve or to other factors must be assessed.
Degree of Stenosis
Insistence that symptoms be present and either disabling or progressive before considering mitral valvuloplasty has proved to be a good method of limiting surgery to patients with hemodynamically significant stenosis. It allows those with only "auscultatory" stenosis to avoid surgery. Although an occasional asymptomatic patient with severe stenosis changes to a rapid deteriorating course, the symptomatic stage of mitral stenosis is generally of gradual onset and there is ample clinical warning before life is threatened and operative risk is significantly increased.
There are patients whose symptoms are atypical or whose history is difficult to interpret. These include patients who tend to minimize symptoms and conceal disability. They often adjust their lives remarkably to their limited capacity. Conversely, there are patients unusually aware of symptoms. This group includes patients with cardiac neurosis or neurocirculatory asthenia. Careful history from family and friends and prolonged observation of the patient may help in clinical assessment. Right ventricular hypertrophy by electrocardiogram or enlargement of the right ventricle and pulmonary artery by fluoroscopy suggests significant stenosis. Often a valid clinical decision can only be made by means of objective tests of cardiac function, e.g., cardiac catheterization, or over-all cardiopulmonary performance, as suggested by Bruce.9 If the lesion is pure mitral stenosis and no other cardiac or pulmonary disease is likely, direct evidence of pulmonary hypertension and elevated pulmonary wedge ("capillary") pressure, especially during exercise, constitute adequate indications for operation. This is one group of patients in which catheterization of the right heart may still be of clinical value.
When, however, the clinical signs of mitral stenosis are equivocal, and particularly when there is also suspicion of mitral insufficiency, aortic valve disease, or myocardial failure, right heart catheterization is not likely to be of diagnostic help, and the method of choice is percutaneous catheterization of the left heart. This The electrocardiogram is often of greater help in estimating the type of enlargement. Unusual enlargement of the left atrium is found most commonly in association with insufficiency, and in the oblique view the enlarged atrium is characteristically low and may rest on the diaphragm. Systolic expansion of this chamber has not proved to be a helpful sign in differentiation. Calcification of the valve usually means that at least some stenosis is present.
Methods for the detection of mitral insufficiency by injection of radiopaque dye into the left atrium or ventricle have been reported but are still to be considered in the experimental stage.
SELECTION OF PATIENTS FOR MITRAL AND AORTIC VALVULOPLASTY
In summary, there is no absolute method of differentiating stenosis from insufficiency clinically. All of the evidence must be weighed and a decision reached after such total evaluation.'5 As will be seen, laboratory study helps little in this problem.
When significant amounts of blood regurgitate backward across the mitral valve in systole, forward mitral valve flow during diastole must increase if aortic valve flow or cardiac output is to be maintained. This increase in systolic flow across a narrowed mitral valve will be possible only if the pressure gradient is increased by a rise in left atrial pressure. In other words, insufficiency superimposed on anatomic stenosis of a valve increases physiologic stenosis by increasing the demand for forward flow. Since there is, as yet, no dependable method of measuring valve flow when regurgitation is present, although current work in our and other laboratories shows some promise that analysis of indicator-dilution curves may help in this regard,'2 this method of estimating valve size by means of left heart catheterization does not apply when there is valvular insufficiency. As a rule, the presence of insufficiency is signaled by a regurgitant wave inscribed on the left atrial pressure tracing. The atrial pressure tracing, however, has little quantitative value, nor does its derivative, the pulmonary wedge pressure tracing. Neither has been found helpful by us in estimating the degree of mitral insufficiency or of stenosis. Nevertheless, analysis of all clinical and physiologic data in a given patient usually permits a correct decision.
Predominant mitral insufficiency constitutes a contraindication to the conventional operation for stenosis. On the other hand, when stenosis predominates and is at least moderate in degree, surgical treatment of the stenosis alone will be followed by worth-while improvement in more than half of the patients even in the presence of insufficiency. In the past 3 years mild to moderate degrees of associated regurgitation seem to have been improved by a simple extracardiac maneuver that involves the insertion of an external baffle that tends to reduce the valvular and atrial herniation and distorts the annulus so that the leaflets approximate better. Definitive correction of regurgitation has been unsatisfactory to date.
Peripheral Embolization
This is one of the great hazards to patients with mitral stenosis, particularly if they are fibrillating. No satisfactory medical preventive treatment has yet evolved. Our experience in this regard is as follows: in 19 per cent of the first 1,000 operated patients one or more clearcut episodes of peripheral embolization had occurred prior to operation. The present risk of developing an operative embolus in patients is 2 per cent in group III and 9 per cent in group IV, but it is twice as great in patients with a history of preoperative embolus. Once the hurdle of operation is safely passed, however, the likelihood of a late embolus appears to be slight. Of the entire group of 913 patients surviving operation 19 have developed late peripheral emboli. Since the average time of follow-up in the series is nearly 3 years, this represents an experience of more than 2,500 patient years or a rate of 0.6 per cent per year. This figure indicates that operation protects against late embolization. This presumably is due to reducing stasis in the atrium by valvuloplasty and removing a nidus of extreme stagnation by concomitant appendectomy. Operation may be recommended as a proper procedure in patients who have had previous emboli. It is probably more reliable and carries less risk than other radical treatments in the prevention of emboli in such patients.
How soon operation should be undertaken after a major peripheral embolism is uncertain. We have had considerable experience with patients operated upon hours, days, and weeks after peripheral embolization. The incidence of operative embolization is no greater than when the operation is delayed. Moreover, even after such a recent embolic phenomenon, thrombi in the atrium and atrial appendage are found at operation in only about half of the cases. Probably the ideal approach is to keep a patient on anticoagulant therapy for 3 or 4 weeks after a peripheral embolus and then operate as soon as possible after the omission of anticoagulant therapy permits the clotting mechanism to re-turn to normal. Occasionally, the hand of the surgeon is forced in patients who are having showers of peripheral emboli. In such instances mitral valvuloplasty may actually become an emergency procedure.
Rheumatic Activity
Rheumatic activity with myocardial failure as opposed to To what extent it will be possible by such technics to apportion symptoms between valvular lesions and myocardial weakness remains to be seen, but the approach promises to be fruitful.
Associated Aortic Valvular Disease
Evidence of aortic valve deformity without significant physiologic effect does not alter the risk and prognosis of mitral valvuloplasty. Significant aortic stenosis requires an elevated left ventricular systolic pressure and increased left ventricular work. In such a situation correction of mitral stenosis alone is improper as the operative risk is increased, the benefit to be expected is uncertain, and the danger of significant postoperative mitral insufficiency quite real. The clinical problem lies in the interpretation of the signs of aortic stenosis. This will be discussed later. Significant aortic stenosis per se indicates direct surgical attack just as mitral stenosis does. If both are significant, they can be corrected simultaneously. Significant aortic insufficiency, generally manifested by a lowered diastolic blood pressure and a dilated left ventricle with increased amplitude of pulsations, contraindicates mitral valvuloplasty, but does not commonly accompany pure severe mitral stenosis. The diastolic murmur heard so frequently along the left sternal border in patients with mitral stenosis is often due to pulmonic rather than aortic insufficiency. 
Associated Pulmonary Disease
Patients with severe pulmonary vascular disease have shown marked postoperative improvement and those with the highest pulmonary arterial pressure often benefit most. Pulmonary hypertension has fallen more rapidly than the vascular changes could be expected to subside. This leads to the hypothesis that pulmonary hypertension may be in part functional.
Significant independent pulmonary disease may affect risk and prognosis. Pulmonary emphysema increases operative risk and favors residual postoperative cardiopulmonary symptoms. Pleural disease may decrease pulmonary reserve and cause early postoperative difficulties. Tests of ventilatory function and occasionally bronchospirometry may be helpful in such problems. Prominent cough and sputum, clubbing of fingers, and polycythemia are findings that should lead to a search for pulmonary disease. An approach through the right chest has been described'9 and might be considered when there is diminished function of the right lung, and left thoracotomy could be most dangerous. Such an awkward approach, however, must be weighed against the significantly poorer quality of valvular surgery per se. Direct surgery requires the surgeon's best effort and any handicap should be gravely considered before acceptance.
Subacute Bacterial Endocarditis
This condition like thyrotoxicosis and acute rheumatic activity should arrest the attention of the careful clinician but, once reasonably excluded, should not constitute a basis for procrastination. Prompt blood cultures should be taken. If positive, surgery is deferred until the condition is controlled.
Pregnancy
Most women with the murmur of mitral stenosis can go through pregnancy without difficulty. Patients with mild symptoms often tolerate pregnancy if carefully managed. It is seldom necessary to add the hazard of an operation at the time of pregnancy. Moreover, women with or without heart disease often retain fluid, complain of dyspnea, and present other symptoms that make it very difficult to determine the extent of actual cardiac embarrassment. Murmurs and other objective cardiac signs are frequently difficult to evaluate during pregnancy. There are, however, patients with pure mitral stenosis who would have been classified in group III or IV prior to pregnancy, patients for whom valvuloplasty would have been clearly indicated. If such patients come under observation for the first time during the first trimester of pregnancy, a mitral operation can be done with little more risk than would obtain in the nonpregnant state and probably less than for the alternative courses of action: either interruption of pregnancy and then valvuloplasty, or continuation of pregnancy under medical management and then a later valvuloplasty. From the fourth to the eighth month the added risk of valvuloplasty during pregnancy is very real and a decision as to the course of action must depend on weighing all factors. After the eighth month even patients in congestive failure should not be operated upon if it can possibly be avoided, since the burden of pregnancy becomes less during the final month.
Refusion
It has been increasingly apparent that the Temporary ligation of the inferior vena cava was aortic regurgitation is probably significant. It must be kept in mind that peripheral vasodilatation may simulate aortic insufficiency, and vasoconstriction, while actually increasing regurgitation, may decrease the peripheral signs. Direct arterial pressure tracings give more accurate information about the absolute level of diastolic and pulse pressures, but do not permit quantitation of aortic regurgitation. When left heart catheterization demonstrates only a slight systolic pressure gradient across the aortic valve in the presence of signs of stenosis and insufficiency, the latter lesion probably predominates and the operation for stenosis is contraindicated. In the presence of aortic insufficiency, standard aortic valve formulas overestimate the severity of aortic stenosis, since the increased forward aortic valve flow (cardiac output plus regurgitant flow) necessitates a larger systolic pressure gradient across the valve. Thus a method to measure total aortic valve flow is needed before the relative degrees of aortic stenosis and aortic insufficiency can be quantitatively assessed by left heart catheterization.
Other Valvular Disease
When mitral stenosis and aortic stenosis coexist and both are hemodynamically severe, the 2 conditions must be corrected at the same operation. Mitral insufficiency increases operative risk but does not contraindicate an operation for aortic stenosis. Such mitral incompetence may be improved after ventricular systolic pressure falls.
Other Factors
Bacterial endocarditis, acute rheumatic fever, and severe congestive heart failure resistant to treatment represent contraindications to surgery. Rheumatic activity is less of a problem in the older age group. Since aortic stenosis is seen mainly in men of middle age and older, chronic bronchitis and pulmonary emphysema coexist not infrequently and should be evaluated. Functionally significant pulmonary emphysema increases operative risk and affects postoperative prognosis adversely. It may even constitute a contraindication to operation.
Summary of the Indications for Operation for
A ortic Stenosis When a patient with clinically pure aortic stenosis and with no contraindications shows progressive disabling cardiovascular symptoms, catheterization of the left heart should be performed to determine the degree of aortic stenosis. If stenosis is severe, operation should be recommended. Contraindications include coronary atherosclerosis, myocardial infarction, severe aortic regurgitation, rheumatic activity, bacterial endocarditis, and intractable congestive heart failure.
Patients with significant aortic stenosis and stationary cardiac symptoms may be considered for operation, provided severe aortic stenosis can be demonstrated hemodynamically.
Patients with asymptomatic severe aortic stenosis may eventually prove to be the best surgical group, but should not be considered for operative treatment until more is known about the long-range effects of aortic valvulotomy. In all probability the limitations of the calcific pathologic process itself will continue to make such "early surgery" improper until valve replacement is possible.
